Loading company…
Beijing contract research organization providing biological reagent production and recombinant protein and antibody development services.
Established in 2007 and based in Beijing, China, the company is a contract research organization focused on biotechnology. It supplies R&D, production, sales and technology for biological reagents and pre-clinical scale production, including recombinant proteins, antibodies, genes and culture medium. The company has 330 employees, and 33% of its core research team holds master's degrees. Its founder, Dr. Liangzhi Xie, has undertaken national 863 program projects. In April 2016 its product SCT400 entered clinical phase III.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in